Literature DB >> 16682062

First case of ivermectin-induced severe hepatitis.

Olivia Veit1, Bernhard Beck, Michael Steuerwald, Christoph Hatz.   

Abstract

Loiasis, caused by the filarial parasite Loa loa, is endemic in West and Central Africa. Ivermectin has been shown to be an effective treatment of loiasis. We report the case of a 20-year-old woman originally from Cameroon who was infected by the L. loa parasite and developed severe hepatitis, identified 1 month after a single dose of ivermectin. Liver biopsy showed intralobular inflammatory infiltrates, confluent necrosis and apoptosis, compatible with drug-induced liver disease. To our knowledge, this is the first case of ivermectin-induced severe liver disease published in the literature.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682062     DOI: 10.1016/j.trstmh.2006.02.003

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Identification and Characterization of Cefazolin-Induced Liver Injury.

Authors:  Saleh A Alqahtani; David E Kleiner; Marwan Ghabril; Jiezhun Gu; Jay H Hoofnagle; Don C Rockey
Journal:  Clin Gastroenterol Hepatol       Date:  2014-12-18       Impact factor: 11.382

Review 2.  Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19.

Authors:  Pierre Kory; Gianfranco Umberto Meduri; Joseph Varon; Jose Iglesias; Paul E Marik
Journal:  Am J Ther       Date:  2021-04-22       Impact factor: 2.688

3.  Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): Assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment.

Authors:  Samuel Wanji; Ebanga-Echi J Eyong; Nicholas Tendongfor; Che J Ngwa; Elive N Esuka; Arnaud J Kengne-Ouafo; Fabrice R Datchoua-Poutcheu; Peter Enyong; Dalen Agnew; Rob R Eversole; Adrian Hopkins; Charles D Mackenzie
Journal:  PLoS Negl Trop Dis       Date:  2017-07-07

4.  Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.

Authors:  Kevin C Kobylinski; Podjanee Jittamala; Borimas Hanboonkunupakarn; Sasithon Pukrittayakamee; Kanchana Pantuwatana; Siriporn Phasomkusolsil; Silas A Davidson; Markus Winterberg; Richard M Hoglund; Mavuto Mukaka; Rob W van der Pluijm; Arjen Dondorp; Nicholas P J Day; Nicholas J White; Joel Tarning
Journal:  Clin Pharmacol Ther       Date:  2019-12-27       Impact factor: 6.875

Review 5.  Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective.

Authors:  Amr Shaaban Hanafy; Sherief Abd-Elsalam
Journal:  World J Gastroenterol       Date:  2020-12-14       Impact factor: 5.742

6.  Protective effect of vitamin C against ivermectin induced nephrotoxicity in different age groups of male wistar rats: bio-histopathological study.

Authors:  Shereen E Tawfeek; Ayat M Domouky; Reham H Abdel-Kareem
Journal:  Anat Cell Biol       Date:  2021-12-31

Review 7.  Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver.

Authors:  Sandeep Satsangi; Nitin Gupta; Parul Kodan
Journal:  J Clin Transl Hepatol       Date:  2021-04-19

8.  Ivermectin-induced fixed drug eruption in an elderly Cameroonian: a case report.

Authors:  Calypse Asangbe Ngwasiri; Martin Hongieh Abanda; Leopold Ndemnge Aminde
Journal:  J Med Case Rep       Date:  2018-09-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.